AbbVie's Phase 3 VERONA trial in HR-MDS showed no overall survival benefit for venetoclax-azacitidine; existing uses of ...

The global STD testing market is set for significant growth, propelled by rising STD cases, tech innovations, and heightened public health awareness. Projected to grow from $11.03 billion in 2025 to ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

The Middle East and Africa point-of-care diagnostics market is set for transformative growth, driven by rising demand for rapid and accurate diagnostic solutions. Valued at US$ 3.18 billion in 2025, ...

The retina has always served as an invaluable, non-invasive portal to the vascular system, with retinal microvascular changes ...

The high-end cellomics market size has grown robustly in recent times, scaling from $2.90 billion in 2024 to $3.15 billion in 2025, marking a compound annual growth rate CAGR of 8.6%. The surge in ...

AI enhances traditional HTA by improving accuracy and efficiency. Artificial intelligence addresses key limitations of ...

Irish women and people who get periods are all too familiar with the stigma surrounding them in Ireland. We have come so far in recent years ...

The microfluidics market is rapidly transforming the landscape of healthcare, diagnostics, pharmaceuticals, and biotechnology ...